• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Esperion

Quote
















Yes, he seemed great. Seems like it could be a good story to tell once approved. Pay seems good 90-120 or so depending on experience. Sounds like they want to pay out nice bonuses out of launch too. Singe rep territories that do not sound extremely large.

was told face to faces would be sometime early Jan.
 








anonymous said:
Trust me when I say this there isn’t much selling done anymore at all. Physicians don’t have the time and they really don’t care what you have to say. The majority of these cardiologist are simply overworked and under paid. They are completely stressed out during the day and have to focus on the volume game. The last thing they have time for or any interest in for that matter is speaking to another smiling face drug rep.. This is the reality of the modern landscape in pharmaceuticals. The industry needs to evolve.
Click to expand...

That's what they were saying back in the 90s but here I am.
 




During phone interview with hiring manager, I was told I should hear whether I'm going to ftf in Dallas. I should hear something this week, or so I was told. Nothing so far and I'm bummed.

Has anyone confirmed they're going to ftf interviews yet?
 








Had a phone. I’m praying I get to go to the live interview. They are pricing for access and already have a very large outcomes study being run. This sounds like a perfect fit. Fingers crossed
 




















f2f hiring events in Philly week of Jan 13th, Los Angeles week of Jan 20th and Dallas week of Jan 27th. Apparently flying in over 300 candidates to Philly throughout the week. What I was told anyway. Supposed to be contacted by Travel for logistics this Monday.
 
























Top Bottom
Back
Quote